Farmers & Merchants Bancorp, Inc. (FMAO) Market Cap & Valuation Ratios
Farmers & Merchants Bancorp, Inc. (FMAO) has a market cap of $503.3M, a trailing P/E of 12.6 and a price-to-sales ratio of 3.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FMAOFarmers & Merchants Bancorp, Inc.Follow FMAO — free
—
Price chart with a free account
- Market cap
- 503.3M
- P/E TTM
- 12.6
- Dividend yield
- 2.5%
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Peers
banks - regional · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| FMAO | 0.5 | 12.6 | 1.31 | 11% | 2.5% | +19% |
| BWFG | 0.5 | 12.5 | 1.66 | 14% | 1.2% | +32% |
| NPB | 0.5 | 6.7 | 0.87 | 15% | 0.6% | +22% |
| NRIM | 0.5 | 7.8 | 1.53 | 21% | 2.7% | +24% |
| WTBA | 0.5 | 13.6 | 1.85 | 15% | 3.3% | +17% |
| OBT | 0.5 | 10.8 | 1.68 | 17% | 1.7% | +10% |
| COFS | 0.5 | 9.3 | 1.06 | 12% | 3.4% | +39% |
| PDLB | 0.5 | 14.6 | 0.89 | 6% | — | +28% |
| CZNC | 0.5 | — | 1.44 | 8% | 3.5% | +28% |
| PBAM | 0.5 | — | 1.73 | — | — | — |
| HBCP | 0.5 | 10.3 | 1.07 | 11% | 2.0% | +8% |
| Median of these 10 | 10.5 | 1.48 | 14% | 2.3% | +24% |
P/E 12.6 vs. a peer median of 10.5; P/B 1.31 vs. 1.48. FMAO's own P/E sits at the 55th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesCZNC and PBAM have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Farmers & Merchants Bancorp, Inc. — questions
- What is Farmers & Merchants Bancorp, Inc.'s market cap?
- $503.3M.
- What is Farmers & Merchants Bancorp, Inc.'s P/E ratio?
- 12.6 on trailing twelve-month earnings to 2026-06-30.
- What is Farmers & Merchants Bancorp, Inc.'s price-to-sales ratio?
- 3.9.
Every figure on this page comes from Farmers & Merchants Bancorp, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.